Project MedBioinformatics promotes the 1st European Conference on Translational Bioinformatics (ECTB 2016)
ECTB is a new series of scientific conferences promoted by the MedBioinformatics project, which aims to hace continuity by means of new editions to be held in UK (2017) and Barcelona (2018).
A team of researchers from the Pompeu Fabra University reveals the important role played by alternative splicing in the development of cancer.
In order to evaluate the limits when designing new organs, scientists at Pompeu Fabra University have defined a morphoespace, a space that contemplates all the possible biological functions and that allows to organize the universe of existing natural and artificial organs.
For the next three days, more than 50 UPF PhD students will be presenting their respective research in just 4 minutes and in front of a jury. The winner will receive a prize of nearly 1,000 euros.
Scientists find the cause of the accumulation of genetic mutations in certain regions of the genome of melanomas and lung cancers
Researchers at Pompeu Fabra University find a deficiency in the DNA repair machinery that explains the higher rate of mutation in certain regions of the genome.
Within the framework of activities for the celebration of its 25 th anniversary, on 1 April Pompeu Fabra University invited the researcher Aaron Ciechanover to deliver a lecture on protein degradation.
Thousands of genes from the umbilical cord change their activity in response to amniotic sac infection in preterm birth
Two researchers at the Hospital de Figueres and Pompeu Fabra University have shed light on the molecular changes that occur in the umbilical cord of premature babies when there is a fetal inflammatory response due to an infection of the amniotic sac, known as intraamniotic infection, during pregnancy.
Jordi García Ojalvo, researcher of Pompeu Fabra University, has collaborated in a study lead by scientists at the Centre for Genomic Regulation (CRG) and August Pi i Sunyer Biomedical Research Institute (IDIBAPS) that identifies for the first time the alterations in the neuronal circuit that impact cerebral cortex physiology and that could be the cause of cognitive deficits in Down Syndrome.
Protein degradation and its applications in cancer, the focus of the lecture by the Nobel Prize for Chemistry Aaron Ciechanover
On 1 April, Pompeu Fabra University, in collaboration with Novartis, invited the researcher Aaron Ciechanover to give a talk about the ubiquitina-proteasome system.
On Thursday, 7 April, comes back the cycle "Progressing with and for you: Scientific Coffees about Rare Diseases" will take place. On this occasion, it will focus on the genetic counseling and diagnostic techniques and it will count with the participation of the DCEXS researcher Clara Serra, among others.